-- Scott Roberts
MONDAY, Jan. 16 (HealthDay News) -- The U.S. Food and Drug
Administration has expanded approval of an endovascular graft to
include ruptures of the aorta, the body's largest artery.
The Gore Tag Thoracic Endoprosthesis was first sanctioned in
2005 to treat aortic bulges called aneurysms, the agency said in a
news release. Use of the graft to treat aortic tears will spare
patients more invasive open chest surgery.
The graft, produced by Flagstaff, Arizona-based W.L. Gore and
Associates, contains a metal mesh frame surrounded by a fabric
tube. Implantation is done via a catheter inserted into a leg
Approval for the new use was granted based on clinical studies
involving 51 people with aortic tears. Gore will follow patients
implanted with the device for five years, the FDA said.
Medline Plus has more about
tears of the aorta.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.